Bioavailability and pharmacokinetic profile of balovaptan, a selective, brain-penetrant vasopressin 1a receptor antagonist, in h
Discovery of Balovaptan, a Vasopressin 1a Receptor Antagonist for the Treatment of Autism Spectrum Disorder | Journal of Medicinal Chemistry
Balovaptan: An Atypical Benzodiazepine With Unique Medicinal Potential - Tripsitter
A white paper on a neurodevelopmental framework for drug discovery in autism and other neurodevelopmental disorders - ScienceDirect
Discovery of Balovaptan, a Vasopressin 1a Receptor Antagonist for the Treatment of Autism Spectrum Disorder | Journal of Medicinal Chemistry
Targeting antidiuretic hormone vasopressin shows promise for autism
48.4 VASOPRESSIN RECEPTOR ANTAGONISM AS A POTENTIAL TREATMENT OPTION FOR THE CORE SYMPTOMS OF ASD: RESULTS OF BALOVAPTAN FROM EA
PDF) Balovaptan and Autism Spectrum Disorder
Balovaptan | ≥99%(HPLC) | hV1a receptor antagonist | AdooQ®
Efficacy and safety of balovaptan for socialisation and communication difficulties in autistic adults in North America and Europe: a phase 3, randomised, placebo-controlled trial - The Lancet Psychiatry
Discovery of Balovaptan, a Vasopressin 1a Receptor Antagonist for the Treatment of Autism Spectrum Disorder | Journal of Medicinal Chemistry
A perspective on molecular signalling dysfunction, its clinical relevance and therapeutics in autism spectrum disorder | SpringerLink
Frontiers | Untangle the Multi-Facet Functions of Auts2 as an Entry Point to Understand Neurodevelopmental Disorders
Balovaptan - Wikipedia
Discovery of Balovaptan, a Vasopressin 1a Receptor Antagonist for the Treatment of Autism Spectrum Disorder | Journal of Medicinal Chemistry
Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications | Signal Transduction and Targeted Therapy
Upcoming events – Roche aims to change autism and Ocular awaits pivotal results | Evaluate
Biomedicines | Free Full-Text | The Biology of Vasopressin
The study design is as explained in Figures 4 and 5. Sal and VPA rats... | Download Scientific Diagram
IJMS | Free Full-Text | Role of Oxytocin and Vasopressin in Neuropsychiatric Disorders: Therapeutic Potential of Agonists and Antagonists
Balovaptan Archives - CmaxInsight
Efficacy and safety of balovaptan for socialisation and communication difficulties in autistic adults in North America and Europe: a phase 3, randomised, placebo-controlled trial - The Lancet Psychiatry
Balovaptan: An Atypical Benzodiazepine With Unique Medicinal Potential - Tripsitter
Clinical Trial – Autism Spectrum Disorder – Efficacy and Safety of Balovaptan | ForPatients-Roche
Discovery of Balovaptan, a Vasopressin 1a Receptor Antagonist for the Treatment of Autism Spectrum Disorder | Journal of Medicinal Chemistry
Biomedicines | Free Full-Text | The Biology of Vasopressin
Balovaptan: An Atypical Benzodiazepine With Unique Medicinal Potential - Tripsitter
